Medication info

Telmisartan and Hydrochlorothiazide Tablets 40/12.5 mg

Prescription medicationTabletOralExpired
Ingredient · strength
Telmisartan›40mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Unimed Pharmaceutical Co., Ltd.
Appearance
White or off-white, round, biconvex tablet
Packaging
10 tablets/blister × 3
Approval status
Expired

MFDS item code 201900666 · Approved 2019.01.25

This product's status changed to Expired on 2024.01.25. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
Adults For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a beverage, with or without food. Before switching to this drug, which contains fixed doses of each component, it is recommended that the doses of the individual components be titrated separately according to the patient. When clinically appropriate, a direct switch from monotherapy to this drug may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given concomitantly as single agents or with the combination product. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this drug to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment Do not administer more than 40/12.5mg of this drug once daily to patients with mild to moderate hepatic impairment. Do not administer this drug to patients with severe hepatic impairment. Thiazide diuretics should be administered with caution to patients with impaired hepatic function. Elderly patients No dose adjustment is necessary.
Child dose
The safety and efficacy of this drug have not been established in children under 18 years of age.

Ingredients

Manufacturer
Unimed Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

This medication is used for the treatment of essential hypertension and is administered to patients whose blood pressure is inadequately controlled with telmisartan alone, helping effectively manage blood pressure.

How to take

Adult dose

Adults For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a beverage, with or without food. Before switching to this drug, which contains fixed doses of each component, it is recommended that the doses of the individual components be titrated separately according to the patient. When clinically appropriate, a direct switch from monotherapy to this drug may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given concomitantly as single agents or with the combination product. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this drug to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment Do not administer more than 40/12.5mg of this drug once daily to patients with mild to moderate hepatic impairment. Do not administer this drug to patients with severe hepatic impairment. Thiazide diuretics should be administered with caution to patients with impaired hepatic function. Elderly patients No dose adjustment is necessary.

Child dose

The safety and efficacy of this drug have not been established in children under 18 years of age.

Precautions

This medication should not be taken during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the fetus. Patients with allergies to any component of this medication or specific liver or kidney diseases should not take this medication. Elderly patients or those with high potassium levels in the blood or impaired liver function should use this medication with special caution. Adverse effects such as dizziness, hypotension, muscle cramps, and indigestion may occur; if any unusual symptoms arise, consult a physician immediately. This medication may interact with other blood pressure medications, diuretics, or potassium supplements; therefore, it is essential to inform your healthcare provider about any other medications being used. Pregnant or breastfeeding women should not take this medication, and those planning to become pregnant should consider switching to other safer blood pressure medications. Overdosage may result in hypotension, electrolyte imbalance, etc., so seek hospital attention if symptoms appear. This medication is not recommended for children under 18 years as its safety and efficacy have not been established. Caution is advised while driving or operating machinery as dizziness may occur during use. Keep out of reach of children and do not transfer to other containers for safety.

Side effects

  • Exacerbation or activation of bronchitis
  • pharyngitis
  • sinusitis
  • systemic lupus erythematosus
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • dizziness
Show 114 more
  • syncope
  • sensory disturbances
  • insomnia
  • sleep disorders
  • visual disturbances
  • temporary blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • pneumonia
  • pulmonary edema
  • diarrhea
  • dry mouth
  • abdominal distension
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • gastritis
  • abnormal liver function
  • liver disorder
  • angioedema
  • erythema
  • pruritus
  • rash
  • increased sweating
  • urticaria
  • low back pain
  • muscle cramps
  • myalgia
  • arthralgia
  • limb pain
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased serum uric acid
  • increased serum creatinine
  • increased serum creatine phosphokinase
  • elevated liver enzymes
  • upper respiratory tract infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hypersensitivity
  • hyperkalemia
  • hypoglycemia
  • bradycardia
  • abdominal discomfort
  • eczema
  • drug rash
  • toxic epidermal rash
  • arthrosis
  • tendon pain
  • renal impairment
  • weakness
  • decreased hemoglobin
  • sialadenitis
  • aplastic anemia
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • neutropenia
  • agranulocytosis
  • necrotizing vasculitis
  • pancreatitis
  • hepatocellular jaundice
  • cholestatic jaundice
  • toxic epidermal necrolysis
  • erythematous lupus-like reaction
  • cutaneous vasculitis
  • photosensitivity reaction
  • reactivation of erythematous lupus
  • weakness
  • interstitial nephritis
  • renal function impairment
  • diabetes
  • fever
  • increased triglycerides
  • acute respiratory distress syndrome
  • nausea
  • gastrointestinal bleeding
  • esophagitis
  • headache
  • tremor
  • facial flushing
  • lethargy
  • fatigue
  • weight loss
  • proteinuria
  • itching
  • myalgia
  • feeling of floating
  • lip and hand tremor
  • sensory hyperesthesia
  • periodontal disease
  • lip dryness
  • vision impairment
  • hypoglycemia
  • hypochloremia
  • hypomagnesemia
  • acute myopia
  • acute closed-angle glaucoma
  • dyspnea
  • fever
  • worsening lung condition
  • hypotension

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture; therefore, it must be stored in a tightly sealed container. The storage temperature should be maintained at room temperature between 1 degree Celsius and 30 degrees Celsius. This will help maintain the medication's efficacy and safety.

Appearance and packaging

Appearance

White or off-white, round, biconvex tablet

Package unit

10 tablets/blister × 3

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.